This IT2022 edition will be organized in 6 sections:
- 1. Assessing possibilities of therapeutic interventions on tumor‐associated inflammation and immune regulatory circuits.
- 2. Protein engineering approaches to get better weapons against cancer, inflammatory and infectious diseases.
- 3. Design of novel cancer vaccines, adoptive cell therapies and immuno‐therapeutic combinations.
- 4. Decrypting the tumor biology to design more effective treatments and biomarkers of its efficacy.
- 5. Application of in vivo imaging, computational biology and high throughput technologies to identify the right targets, the right effectors and the right tumor.
- 6. What can we learn from COVID‐19 experiences and what can be relevant for cancer control.